Daidzein and Equol: Ex Vivo and In Silico Approaches Targeting COX-2, iNOS, and the Canonical Inflammasome Signaling Pathway.

导出 OA

翻译打印收藏纠错

作者： Yazmín K,Márquez-Flores ^[1] ; Elizdath,Martínez-Galero ^[1] ; José,Correa-Basurto ^[2] ; Yudibeth,Sixto-López ^[2] ; Isabel,Villegas ^[3] ; María Á,Rosillo ^[4] ; Ana,Cárdeno ^[4] ; Catalina,Alarcón-de-la-Lastra ^[4]

作者单位： Departamento de Farmacia, Escuela Nacional de Ciencias Biológicas, Campus Zacatenco, Instituto Politécnico Nacional, Av. Wilfrido Massieu s/n Col. Zacatenco, Mexico City C.P. 07738, Mexico. ^[1] Laboratorio de Diseño y Desarrollo de Nuevos Fármacos y Productos Biotecnológicos, Escuela Superior de Medicina, Instituto Politécnico Nacional, Plan de San Luis y Díaz Mirón s/n, Col. Santo Tomas, Mexico City C.P. 11340, Mexico. ^[2] Departamento de Química Farmacéutica y Orgánica, Facultad de Farmacia, Campus de Cartuja, Universidad de Granada, 18071 Granada, Spain. ^[3] Department of Pharmacology, Faculty of Pharmacy, University of Seville, Professor García González Street 2, 41012 Seville, Spain. ^[4]

关键词 daidzein docking equol inflammasome inflammation soy

DOI 10.3390/ph17050647

PMID 38794217

发布时间 2024-05-27

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Pharmaceuticals (Basel, Switzerland)

2024年17卷5期

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Daidzein and Equol: Ex Vivo and In Silico Approaches Targeting COX-2, iNOS, and the Canonical Inflammasome Signaling Pathway.

Pharmaceuticals (Basel, Switzerland)

相似文献

Pharmaceuticals (Basel, Switzerland)

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Daidzein and Equol: Ex Vivo and In Silico Approaches Targeting COX-2, iNOS, and the Canonical Inflammasome Signaling Pathway.

Pharmaceuticals (Basel, Switzerland)

相似文献

Pharmaceuticals (Basel, Switzerland)

相关期刊

检索历史清除